Insider · CIK 0001283301

HENSON HEIDI

Reports to the SEC for 7 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001283301

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-18	PEPGPepGen Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+34K sh	—	—	34,000
2026-03-02	CATXPerspective Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2026-01-09	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+30.5K sh	—	—	85,725
2025-06-04	PEPGPepGen Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2025-03-03	CATXPerspective Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2025-01-09	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+15.8K sh	—	—	55,269
2024-12-04	CATXPerspective Therapeutics, Inc.P Purchase	Director	PPurchase	+26K sh	$3.85	+$100K	25,975
2024-06-20	CATXPerspective Therapeutics, Inc. · Stock option (right to buy)A Award	Director	AAward	+23K sh	—	—	23,000
2024-06-20	PEPGPepGen Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2024-01-09	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+19.5K sh	—	—	39,480
2023-12-12	CATXPerspective Therapeutics, Inc. · Stock Options (right to buy)A Award	Director	AAward	+230K sh	—	—	930,000
2023-08-31	PARDES BIOSCIENCES, INC.U Disposition from Tender	Chief Financial Officer	UDisposition from Tender	−317K sh	—	—	0
2023-08-31	PARDES BIOSCIENCES, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−156K sh	—	—	0
2023-08-31	PARDES BIOSCIENCES, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−242K sh	—	—	0
2023-08-31	PARDES BIOSCIENCES, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−160K sh	—	—	0
2023-08-31	PARDES BIOSCIENCES, INC.Stock Option (Right to Buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−125K sh	—	—	0
2023-06-22	PEPGPepGen Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2023-06-02	CATXPerspective Therapeutics, Inc. · Stock Options (right to buy)A Award	Director	AAward	+470K sh	—	—	470,000
2023-06-02	CATXPerspective Therapeutics, Inc. · Stock Options (right to buy)A Award	Director	AAward	+230K sh	—	—	700,000
2023-02-01	PARDES BIOSCIENCES, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+156K sh	—	—	156,250
2023-01-09	LSTALISATA THERAPEUTICS, INC.A Award	Director	AAward	+20K sh	—	—	20,000
2022-09-14	PARDES BIOSCIENCES, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+125K sh	—	—	125,000
2022-05-06	PEPGPepGen Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.7K sh	—	—	11,667
2022-02-01	PARDES BIOSCIENCES, INC.Stock Option (Right to Buy)A Award	Chief Financial Officer	AAward	+160K sh	—	—	160,000
2018-01-24	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Chief Financial Officer	AAward	+81K sh	—	—	81,000
2017-01-23	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2016-12-13	KURAKura Oncology, Inc.G Gift	Chief Financial Officer	GGift	−2,596 sh	—	—	245,000
2016-01-29	KURAKura Oncology, Inc. · Option to purchase common stockA Award	Chief Financial Officer	AAward	+80K sh	—	—	80,000
2015-11-11	KURAKura Oncology, Inc.G Gift	Chief Financial Officer	GGift	−3,000 sh	—	—	247,596
2004-04-12	ANADYS PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director of Finance	AAward	+5,000 sh	—	—	22,034

Recent filings

Accepted (ET)
Jun 224
HENSON HEIDI0001835597-26-000029
SEC(opens sec.gov)
Mar 44
HENSON HEIDI0001283301-26-000008
SEC(opens sec.gov)
Jan 134
HENSON HEIDI0001283301-26-000003
SEC(opens sec.gov)
Jun 64
HENSON HEIDI0001127602-25-016931
SEC(opens sec.gov)
Mar 54
HENSON HEIDI0000950170-25-033649
SEC(opens sec.gov)
Jan 134
HENSON HEIDI0001283301-25-000002
SEC(opens sec.gov)
Dec 64
HENSON HEIDI0000950170-24-134067
SEC(opens sec.gov)
Jun 244
HENSON HEIDI0000950170-24-076719
SEC(opens sec.gov)
Jun 214
HENSON HEIDI0001127602-24-019124
SEC(opens sec.gov)
Jan 114
HENSON HEIDI0001283301-24-000002
SEC(opens sec.gov)
Dec 144
HENSON HEIDI0001437749-23-034470
SEC(opens sec.gov)
Aug 314
HENSON HEIDI0001209191-23-047821
SEC(opens sec.gov)
Jun 264
HENSON HEIDI0001127602-23-019406
SEC(opens sec.gov)
Jun 64
HENSON HEIDI0001437749-23-016757
SEC(opens sec.gov)
Feb 34
HENSON HEIDI0001209191-23-006867
SEC(opens sec.gov)

Companies

Address

C/O KORSANA BIOSCIENCES, INC. 203 CRESCENT STREET, SUITE 503

WALTHAM, MA, 02453